Jounce Therapeutics Inc buy Slaandjivaa
Start price
14.03.17
/
50%
€19.65
Target price
24.03.17
€25.26
Performance (%)
17.43%
End price
24.03.17
€23.07
Summary
This prediction ended on 24.03.17 with a price of €23.07. The prediction had a final performance of 17.43%. Slaandjivaa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Jounce Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | -0.046% | 5.960% | 7.403% | 65.851% |
| iShares Nasdaq 100 | 0.922% | 3.693% | 28.138% | 93.298% |
| iShares Nikkei 225® | 3.014% | 6.638% | 48.886% | 89.079% |
| iShares S&P 500 | -0.359% | 2.747% | 22.530% | 71.942% |
Comments by Slaandjivaa for this prediction
In the thread Jounce Therapeutics Inc diskutieren
Unschlaff
Achten:
http://seekingalpha.com/article/4054590-buy-shares-lesser-known-celgene-partner
(Vom Mitglied beendet)


